Word

HETSIFA

Status

Registered

Status Code

700

Status Date

Tuesday, December 7, 2021

Serial Number

88025090

Registration Number

6583852

Registration Date

Tuesday, December 7, 2021

Mark Type

4000

Filing Date

Tuesday, July 3, 2018

Published for Opposition

Tuesday, March 26, 2019

Trademark Owner History

FUZIONAIRE THERANOSTICS, INC. -
Fuzionaire, Inc. - Original Registrant

Classifications

5 Reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents for use in radiolabels and radiopharmaceuticals for medical or veterinary purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, medical, theranostic, therapeutic, and quantitation reagents for use in radiopharmaceuticals for clinical medical and veterinary diagnostic purposes

1 chemical preparations for scientific purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiolabels for non-medical purposes; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiotracers for laboratory use; biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents and reagent kits comprised of biochemical, biological, biomarker, chemical, diagnostic, imaging, labelling, theranostic, and quantitation reagents for scientific use for use in radiolabeled pharmaceutical candidates for non-medical laboratory evaluation and drug discovery purposes

Trademark Events

Dec 1, 2023

Teas Change Of Correspondence Received

Dec 1, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 1, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Sep 13, 2023

Automatic Update Of Assignment Of Ownership

Dec 7, 2021

Registered-Principal Register

Nov 4, 2021

Notice Of Acceptance Of Statement Of Use E-Mailed

Nov 3, 2021

Allowed Principal Register - Sou Accepted

Oct 20, 2021

Notice Of Approval Of Extension Request E-Mailed

Oct 19, 2021

Statement Of Use Processing Complete

Oct 13, 2021

Use Amendment Filed

Oct 19, 2021

Sou Extension 5 Granted

Oct 13, 2021

Sou Extension 5 Filed

Oct 19, 2021

Case Assigned To Intent To Use Paralegal

Oct 13, 2021

Sou Teas Extension Received

Oct 13, 2021

Teas Statement Of Use Received

May 6, 2021

Notice Of Approval Of Extension Request E-Mailed

May 4, 2021

Sou Extension 4 Granted

May 4, 2021

Sou Extension 4 Filed

May 4, 2021

Sou Teas Extension Received

Nov 12, 2020

Notice Of Approval Of Extension Request E-Mailed

Nov 10, 2020

Sou Extension 3 Granted

Nov 10, 2020

Sou Extension 3 Filed

Nov 10, 2020

Sou Teas Extension Received

May 8, 2020

Notice Of Approval Of Extension Request E-Mailed

May 6, 2020

Sou Extension 2 Granted

May 6, 2020

Sou Extension 2 Filed

May 6, 2020

Sou Teas Extension Received

Oct 23, 2019

Notice Of Approval Of Extension Request E-Mailed

Oct 21, 2019

Sou Extension 1 Granted

Oct 21, 2019

Sou Extension 1 Filed

Oct 21, 2019

Sou Teas Extension Received

May 21, 2019

Noa E-Mailed - Sou Required From Applicant

Mar 26, 2019

Official Gazette Publication Confirmation E-Mailed

Mar 26, 2019

Published For Opposition

Mar 6, 2019

Notification Of Notice Of Publication E-Mailed

Feb 15, 2019

Assigned To Lie

Feb 4, 2019

Approved For Pub - Principal Register

Feb 1, 2019

Teas/Email Correspondence Entered

Jan 31, 2019

Correspondence Received In Law Office

Jan 31, 2019

Teas Request For Reconsideration Received

Jan 28, 2019

Notification Of Final Refusal Emailed

Jan 28, 2019

Final Refusal E-Mailed

Jan 28, 2019

Final Refusal Written

Jan 3, 2019

Teas/Email Correspondence Entered

Jan 2, 2019

Correspondence Received In Law Office

Jan 2, 2019

Teas Response To Office Action Received

Oct 23, 2018

Notification Of Non-Final Action E-Mailed

Oct 23, 2018

Non-Final Action E-Mailed

Oct 23, 2018

Non-Final Action Written

Oct 23, 2018

Assigned To Examiner

Jul 10, 2018

New Application Office Supplied Data Entered

Jul 6, 2018

New Application Entered